Erythema multiforme as a reaction to imiquimod 5% cream.

We describe a patient with erythema multiformefollowing a local site reaction after the use of topicalimiquimod 5% cream and review the literature forprevious reports of this cutaneous adverse effect. PMID: 28329504 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28329504?dopt=Abstract

Source: Dermatol Online J - February 15, 2017 Category: Dermatology Authors: Yanes DA, Kaffenberger JA, Carr DR Tags: Dermatol Online J Source Type: research

More News: Dermatology